Trialstat Solutions

[Trialstat Solutions @TrialStatEDC]

Anticipating the Future: 5 essential questions to help guide your next eClinical technology purchase - https://t.co/KGOHcYOuZI

[Trialstat Solutions @TrialStatEDC]

Anticipating the Future: A Guide to Smart eClinical Technology Investments

https://t.co/YS5UmOrIxR

#ClinicalResearch #ClinicalTrials #EDC

[Trialstat Solutions @TrialStatEDC]

SkylineDx and NeraCare enter a strategic partnership to advance precision medicine for early-stage melanoma

https://t.co/0puYV7D2NN

#ClinicalResearch #ClinicalTrials #Melanoma #MolecularDiagnostic

[Trialstat Solutions @TrialStatEDC]

Intergalactic Therapeutics to Present Updated Data From Its Non-Viral Gene Therapy Platform at the 2023 Retinal Cell and Gene Therapy Innovation Summit

https://t.co/tqOS3ilWoT

#ABCA4Gene #ClinicalResearch #ClinicalTrials #Non-ViralGene

[Trialstat Solutions @TrialStatEDC]

Elucida Oncology Announces Positive Early Phase 1 Safety Data Along with Preclinical Data for the Treatment of Brain Metastases for ELU001, an Anti-Folate Receptor Alpha C’Dot Drug C

https://t.co/q0xF4FHs7y

#AlphaC’Dot #Anti-FolateReceptor #ClinicalResearch #ClinicalTrials

[Trialstat Solutions @TrialStatEDC]

Oblato Announces the First Enrollment in a Phase 1 Clinical Trial for an Oral Formulation of OKN-007 in Recurrent High-Grade Glioma Patients in the USA

https://t.co/u7abwZS22h

#BrainCancer #ClinicalResearch #ClinicalTrials #Oblato

[Trialstat Solutions @TrialStatEDC]

Totus Medicines Announces First Patient Dosed in Phase 1 Trial of TOS-358 for the Treatment Of Select Solid Tumors

https://t.co/LT33HXlRG8

#ClinicalResearch #ClinicalTrials #Phase1 #PI3Kα

[Trialstat Solutions @TrialStatEDC]

Verismo Therapeutics Presents STAR-101 Clinical Trial Design at the Annual Cholangiocarcinoma Foundation Conference

https://t.co/tbdXOMVmI3

#Cholangiocarcinoma #ClinicalResearch #ClinicalTrials #Phase1KIR-CAR

[Trialstat Solutions @TrialStatEDC]

Ocugen Announces Positive Preliminary Safety and Efficacy Results from the Phase 1/2 Trial of OCU400, a Modifier Gene Therapy Product Candidate, for the Treatment of Retinitis Pigmentosa and

https://t.co/BMw6xqA3Sd

#ClinicalResearch #ClinicalTrials #GeneTherapy #NHRGene

[Trialstat Solutions @TrialStatEDC]

Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 2 Study of AMX0035 for the Treatment of Wolfram Syndrome

https://t.co/WgjpcCoBJt

#AMX0035 #AmylyxPharmaceutical #ClinicalResearch #ClinicalTrials

[Trialstat Solutions @TrialStatEDC]

Palisade Bio Announces Enrollment of First Patient in Newsoara Phase 3 Clinical Trial Evaluating LB1148

https://t.co/Sx4EszJd56

#ClinicalResearch #ClinicalTrials #gastrointestinal #LB1148

[Trialstat Solutions @TrialStatEDC]

Alterity Therapeutics Enrolls First Patient in the United Kingdom in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

https://t.co/cfBfnTCJIV

#AlterityTherapeutics #ATH434 #ClinicalResearch #ClinicalTrials

[Trialstat Solutions @TrialStatEDC]

Vega Therapeutics Initiates Clinical Trial Program for VGA039, a First‑in‑Class Antibody Therapy for von Willebrand Disease

https://t.co/VZsyRgRKfX‑in‑class-antibody-therapy-for-von-willebrand-disease/

#ClinicalResearch #ClinicalTrials #Phase1 #PressRelease

[Trialstat Solutions @TrialStatEDC]

MAPS PBC Announces Positive Topline Results from Long-Term Observational Follow-Up Study on MDMA-Assisted Therapy for Treatment of PTSD

https://t.co/x1XmUwySN6

#ClinicalResearch #ClinicalTrials #MAPSPBC #MDMA-assistedTherapy

[Trialstat Solutions @TrialStatEDC]

Endogena Therapeutics Completes Dose Escalation in the Phase 1/2a Clinical Trial of EA-2353 for the Treatment of Retinitis Pigmentosa

https://t.co/a3SXx60gAJ

#ClinicalResearch #ClinicalTrials #EA-2353 #EndogenaTherapeutics

[Trialstat Solutions @TrialStatEDC]

Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia

https://t.co/BlFmpF0XEX

#CBP-4888 #ClinicalResearch #ClinicalTrials #ComancheBiopharma

[Trialstat Solutions @TrialStatEDC]

Vaxcyte Doses First Participants in Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants

https://t.co/yluZwdp3CT

#ClinicalResearch #ClinicalTrials #Inc. #Phase2

[Trialstat Solutions @TrialStatEDC]

Seer’s Proteograph™ Product Suite identifies undiscovered links between protein variants and lung cancer progression

https://t.co/lHpHbPUAQW

#ClinicalResearch #ClinicalTrials #LDHB #LungCancer

[Trialstat Solutions @TrialStatEDC]

Bigfoot Biomedical Acquires Reinforcement Learning Algorithm for Insulin Titration Developed at McGill University

https://t.co/YXM89xj6vY

#BigfootBiomedical #ClinicalResearch #ClinicalTrials #HCPs

[Trialstat Solutions @TrialStatEDC]

Akero Therapeutics Announces Positive End-of-Phase 2 Meeting with the FDA and SYNCHRONY Phase 3 Program for Efruxifermin in NASH

https://t.co/47PopTYK6D

#AkeroTherapeutics #ClinicalResearch #ClinicalTrials #Efruxifermin